Granite Investment Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Granite Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$55.23 - $79.93 $3.67 Million - $5.32 Million	-66,514 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$30.2 - $56.98 $61,034 - $115,156	2,021 Added 3.13%	66,514 $3.7 Million
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $1.18 Million - $1.83 Million	-47,526 Reduced 42.43%	64,493 $1.91 Million
Q4 2019 Feb 10, 2020	BUY	$25.43 - $36.67 $1.04 Million - $1.5 Million	40,786 Added 57.26%	112,019 $4.06 Million
Q3 2019 Nov 12, 2019	BUY	$23.0 - $27.97 $16,422 - $19,970	714 Added 1.01%	71,233 $1.94 Million

Q2 2019 Aug 07, 2019	BUY	$22.81 - $28.48 $1.61 Million - $2.01 Million	70,519 New	70,519 $1.7 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.